RECOMBINANT VIRUSES AND THEIR USE FOR TREATMENT OF ATHEROSCLEROSIS AND OTHER FORMS OF CORONARY ARTERY DISEASE AND METHOD, REAGENT, AND KIT FOR EVALUATING SUSCEPTIBILITY TO SAME

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

13763613

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Recombinant viruses comprising a heterologous. DNA sequence coding for a lipase involved in lipoprotein metabolism. The invention also concerns the preparation and use in therapy of said recombinant viruses, especially for the treatment or prevention of dyslipoproteinemia-related pathologies.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AVENTIS PHARMA S AFRENCH ANTHONY

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BENOIT, Patrick Paris, FR 20 182
DENEFLE, Patrice Saint Maur, FR 35 188
PERRICAUDET, Michel Ecrosnes, FR 60 654

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation